Molecular IP
Intellectual Property for Life Sciences, Chemistry and Biotechnology

By Neil C. Maskeri The Biologics Price Competition and Innovation Act of 2009 (BPCIA) established an abbreviated approval process for biosimilar applications.  Subsection (k) of the BPCIA allows the submission… read more

By Robert D. Leonard On December 15, 2016, Idenix Pharmaceuticals LLC, a subsidiary of Merck & Co., was awarded $2.54 billion for infringement of its hepatitis C virus (HCV) treatment… read more

By Steven M. Kellner Being billed as one of the most important developments in biotechnology of this decade, if not this generation, the gene-editing technology Clustered Regularly Interspaced Short Palindromic… read more

By: Danielle N. Gross, Ph.D. With the presumptive repeal of the Affordable Care Act (ACA) and the unlikely ratification of the Trans-Pacific Partnership (TPP) agreement, what are some of the… read more